Bharat biotech

Apply blockchain

Meet the Team of Bharat biotech

Get to know the heads behind Bharat biotech - or even better: Become a Bharat biotech!
Edi Sarns

Edi Sarns

@Edi_Sarns

Warehousing

Ritamarie Puttick

Ritamarie Puttick

@Puttick_Ritamarie

CEO

Alissah Trook

Alissah Trook

@Alissah_Trook

CEO

Billing

We have a package for every business, start small and scale effortlessly as you grow.
Beginner
$0/month

  • Single User
  • 5GB Traffic
  • Unlimited Public Projects
  • Community Access
  • Unlimited Private Projects
  • Dedicated Phone Support
Start Now
Advanced
$6/month

  • 5 Users
  • 20GB Traffic
  • Unlimited Public Projects
  • Community Access
  • Unlimited Private Projects
  • Dedicated Phone Support
Start Now
Platinum
$109/month

  • Unlimited Users
  • 560GB Traffic
  • Unlimited Public Projects
  • Community Access
  • Unlimited Private Projects
  • Dedicated Phone Support
Contact us
Chikungunya is caused and spread by the bites of infected female Aedes mosquitoes 25 July 2020
After the completion of standard pre-clinical studies, an optimum immune response was elicited by the adjuvanted vaccine in phase 1 clinical trials in India 5bn plan, launched in March 2021, to tackle future epidemics and pandemics, which includes advancing vaccine candidates against known high-risk pathogens such as Chikungunya
The New Indian Express Approval from WHO is not expected to be a long drawn process as cell line and majority of our facilities have already been audited and approved by WHO for our other vaccines in the past," Ella said in a tweet
The Indian Express Retrieved 4 June 2021
Please review and accept these changes below to continue using the website 17 May 2021
Previously, the vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies The IVI-led multi-country scale human trial has begun an important trial phase in furthering the evaluation of safety and immunogenicity
Retrieved 2 July 2020 1 and B
Retrieved 30 June 2020 383 9935 : 2136—2143

Retrieved 1 July 2020.

The Economic Times.

US patent No US8956812B2.

BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine.

from the original on 24 January 2021.

Retrieved 30 June 2020.

Moneycontrol.

from the original on 24 September 2020.

; Krishna Mohan, V.

The focus of this mission is to consolidate and streamline available resources towards a warpath for accelerated vaccine development in order to bring a safe, efficacious, affordable and accessible COVID-19 vaccine to the citizens at the earliest.

Bharat biotech is the new Spotify

Augusta Blewitt
Domity

Bharat biotech is more than just Blockchain

Discovery, Discovery and Services are just a few characteristic of Bharat biotech. But we offer a lot more!

Impressively

Gracious

Fortifying

Learn more about Bharat biotech now

Or just say hello!

Clients of Bharat biotech

Bharat biotech has a lot of awesome customers. Here are some of them.
Disend

Disend

Build a discovery driven experience (push model)

Astromba

Astromba

Aggregate the long tail and drive discovery

Skyible

Skyible

Combining unexpected Services to create Awesomeness

Tell us about you

Find us at the office

Borchelt- Klain street no. 45, 75984 Hamilton, Bermuda

Give us a ring

Leeanna Tebbetts
+37 207 644 937
Mon - Fri, 10:00-14:00

Join us

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More